Here are some fun things you may not know about neuropharmacology.
When we did begin to develop treatments, it was mainly by accident.
The results were mixed, but they did happen upon derivatives like promethazine.
Also, the particular sedative properties of promethazine turned out to be beneficial to patients with Parkinson's disease.
Which wasn't nothing, to be fair.
Until quite recently, we didn't even know that mechanism existed. Knowing things helps, obviously.
Here's the thing, though.
No one knows how it works.
Is this starting to sound familiar?
First, modafinil is centrally active, which means it acts on the central nervous system. The main component of the central nervous system is the brain.
You put novel organic compounds in there, basically anything could happen. It probably won't, but could.
Sometimes bad shit happens to them. I mean, some of them are tech bros with cyborg complexes, and they deserve it. But still.
Meh. I mean, maybe?
But it's still someone's job to write all this stuff down. And therefore: scary lists of side effects.
However, while clinical trials are generally well designed and regulated, they're focused on therapeutic endpoints and side effect data tends to be captured incidentally.
Brains are still vastly complicated and medicine still proceeds, quite literally, by trial and error.
Thanks for coming, everyone. Grab a muffin and a handout.